185 related articles for article (PubMed ID: 23468915)
1. Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer.
Chao A; Lai CH; Tsai CL; Hsueh S; Hsueh C; Lin CY; Chou HH; Lin YJ; Chen HW; Chang TC; Wang TH
PLoS One; 2013; 8(2):e57084. PubMed ID: 23468915
[TBL] [Abstract][Full Text] [Related]
2. Immunohistological analysis of stress-induced phosphoprotein 1 in ovarian cancer patients with low serum cancer antigen 125 levels.
Chao A; Lee LY; Hsueh C; Lin CY; Tsai CL; Chao AS; Lin CT; Chou HH; Chang TC; Wang TH
Taiwan J Obstet Gynecol; 2013 Jun; 52(2):185-91. PubMed ID: 23915849
[TBL] [Abstract][Full Text] [Related]
3. Expression of stress-induced phosphoprotein1 (STIP1) is associated with tumor progression and poor prognosis in epithelial ovarian cancer.
Cho H; Kim S; Shin HY; Chung EJ; Kitano H; Hyon Park J; Park L; Chung JY; Hewitt SM; Kim JH
Genes Chromosomes Cancer; 2014 Apr; 53(4):277-88. PubMed ID: 24488757
[TBL] [Abstract][Full Text] [Related]
4. Secreted stress-induced phosphoprotein 1 activates the ALK2-SMAD signaling pathways and promotes cell proliferation of ovarian cancer cells.
Tsai CL; Tsai CN; Lin CY; Chen HW; Lee YS; Chao A; Wang TH; Wang HS; Lai CH
Cell Rep; 2012 Aug; 2(2):283-93. PubMed ID: 22884369
[TBL] [Abstract][Full Text] [Related]
5. Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation.
Wang TH; Chao A; Tsai CL; Chang CL; Chen SH; Lee YS; Chen JK; Lin YJ; Chang PY; Wang CJ; Chao AS; Chang SD; Chang TC; Lai CH; Wang HS
Mol Cell Proteomics; 2010 Sep; 9(9):1873-84. PubMed ID: 20501939
[TBL] [Abstract][Full Text] [Related]
6. Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma.
Wang J; You H; Qi J; Yang C; Ren Y; Cheng H
Oncotarget; 2017 Mar; 8(10):17012-17026. PubMed ID: 28199984
[TBL] [Abstract][Full Text] [Related]
7. JAK2-Mediated Phosphorylation of Stress-Induced Phosphoprotein-1 (STIP1) in Human Cells.
Chao A; Liao MJ; Chen SH; Lee YS; Tsai CN; Lin CY; Tsai CL
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269562
[TBL] [Abstract][Full Text] [Related]
8. Stress-induced phosphoprotein 1 promotes pancreatic cancer progression through activation of the FAK/AKT/MMP signaling axis.
Jing Y; Liang W; Liu J; Zhang L; Wei J; Zhu Y; Yang J; Ji K; Zhang Y; Huang Z
Pathol Res Pract; 2019 Nov; 215(11):152564. PubMed ID: 31547977
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
[TBL] [Abstract][Full Text] [Related]
10. Stress-induced phosphoprotein 1 facilitates breast cancer cell progression and indicates poor prognosis for breast cancer patients.
Lin L; Wen J; Lin B; Xia E; Zheng C; Ye L; Wang Y; Wang O; Chen Y
Hum Cell; 2021 May; 34(3):901-917. PubMed ID: 33665786
[TBL] [Abstract][Full Text] [Related]
11. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
13. Stress-induced phosphoprotein-1 maintains the stability of JAK2 in cancer cells.
Tsai CL; Chao A; Jung SM; Tsai CN; Lin CY; Chen SH; Sue SC; Wang TH; Wang HS; Lai CH
Oncotarget; 2016 Aug; 7(31):50548-50563. PubMed ID: 27409672
[TBL] [Abstract][Full Text] [Related]
14. Autocrine STIP1 signaling promotes tumor growth and is associated with disease outcome in hepatocellular carcinoma.
Chen Z; Xu L; Su T; Ke Z; Peng Z; Zhang N; Peng S; Zhang Q; Liu G; Wei G; Guo Y; He M; Kuang M
Biochem Biophys Res Commun; 2017 Nov; 493(1):365-372. PubMed ID: 28887036
[TBL] [Abstract][Full Text] [Related]
15. [STIP1 correlates with tumor immune infiltration and prognosis as a potential immunotherapy target: a pan-cancer bioinformatics analysis].
Guan S; Shen Z; Lin M; Deng H; Fang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1179-1193. PubMed ID: 37488801
[TBL] [Abstract][Full Text] [Related]
16. HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up.
Geisler JP; Tammela JE; Manahan KJ; Geisler HE; Miller GA; Zhou Z; Wiemann MC
Eur J Gynaecol Oncol; 2004; 25(2):165-8. PubMed ID: 15032273
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of STIP1 inhibits the invasion of CD133‑positive cancer stem‑like cells of the osteosarcoma MG63 cell line via the PI3K/Akt and ERK1/2 pathways.
Wang JH; Gong C; Guo FJ; Zhou X; Zhang MS; Qiu H; Chao TF; Liu Y; Qin L; Xiong HH
Int J Mol Med; 2020 Dec; 46(6):2251-2259. PubMed ID: 33125116
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.
Moran-Jones K; Gloss BS; Murali R; Chang DK; Colvin EK; Jones MD; Yuen S; Howell VM; Brown LM; Wong CW; Spong SM; Scarlett CJ; Hacker NF; Ghosh S; Mok SC; Birrer MJ; Samimi G
Oncotarget; 2015 Dec; 6(42):44551-62. PubMed ID: 26575166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
